320 related articles for article (PubMed ID: 16849521)
21. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.
Gontarewicz A; Balabanov S; Keller G; Panse J; Schafhausen P; Bokemeyer C; Fiedler W; Moll J; Brümmendorf TH
Leuk Res; 2008 Dec; 32(12):1857-65. PubMed ID: 18514829
[TBL] [Abstract][Full Text] [Related]
22. Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells.
Albero MP; Vaquer JM; Andreu EJ; Villanueva JJ; Franch L; Ivorra C; Poch E; Agirre X; Prosper F; Pérez-Roger I
Oncogene; 2010 Jun; 29(22):3276-86. PubMed ID: 20305692
[TBL] [Abstract][Full Text] [Related]
23. Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells.
Forster K; Obermeier A; Mitina O; Simon N; Warmuth M; Krause G; Hallek M
Ann Hematol; 2008 Mar; 87(3):183-93. PubMed ID: 17960378
[TBL] [Abstract][Full Text] [Related]
24. Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment.
Crowley LC; Elzinga BM; O'Sullivan GC; McKenna SL
Am J Hematol; 2011 Jan; 86(1):38-47. PubMed ID: 21132731
[TBL] [Abstract][Full Text] [Related]
25. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
Yu C; Krystal G; Dent P; Grant S
Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S
Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828
[TBL] [Abstract][Full Text] [Related]
27. Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia.
Guo Y; Li Y; Shan Q; He G; Lin J; Gong Y
Int J Biochem Cell Biol; 2015 Aug; 65():1-11. PubMed ID: 25979368
[TBL] [Abstract][Full Text] [Related]
28. Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells.
Lavallard VJ; Pradelli LA; Paul A; Bénéteau M; Jacquel A; Auberger P; Ricci JE
Cancer Res; 2009 Apr; 69(7):3013-20. PubMed ID: 19318579
[TBL] [Abstract][Full Text] [Related]
29. A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib.
Mancini M; Corradi V; Petta S; Barbieri E; Manetti F; Botta M; Santucci MA
J Pharmacol Exp Ther; 2011 Mar; 336(3):596-604. PubMed ID: 21041536
[TBL] [Abstract][Full Text] [Related]
30. Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines.
Desplat V; Belloc F; Lagarde V; Boyer C; Melo JV; Reiffers J; Praloran V; Mahon FX
Cancer; 2005 Jan; 103(1):102-10. PubMed ID: 15558795
[TBL] [Abstract][Full Text] [Related]
31. STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells.
Greene LM; Kelly L; Onnis V; Campiani G; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2007 Apr; 321(1):288-97. PubMed ID: 17202400
[TBL] [Abstract][Full Text] [Related]
32. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice.
Peters DG; Klucher KM; Perlingeiro RC; Dessain SK; Koh EY; Daley GQ
Oncogene; 2001 May; 20(21):2636-46. PubMed ID: 11420675
[TBL] [Abstract][Full Text] [Related]
33. High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion.
Keeshan K; Cotter TG; McKenna SL
Leukemia; 2002 Sep; 16(9):1725-34. PubMed ID: 12200687
[TBL] [Abstract][Full Text] [Related]
34. A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe.
Martinez-Castillo M; Bonilla-Moreno R; Aleman-Lazarini L; Meraz-Rios MA; Orozco L; Cedillo-Barron L; Cordova EJ; Villegas-Sepulveda N
PLoS One; 2016; 11(11):e0165971. PubMed ID: 27832139
[TBL] [Abstract][Full Text] [Related]
35. Survivin overexpression correlates with an apoptosis-resistant phenotype in chronic myeloid leukemia cells.
Nestal de Moraes G; Silva KL; Vasconcelos FC; Maia RC
Oncol Rep; 2011 Jun; 25(6):1613-9. PubMed ID: 21431279
[TBL] [Abstract][Full Text] [Related]
36. The case for Survivin as mitotic regulator.
Lens SM; Vader G; Medema RH
Curr Opin Cell Biol; 2006 Dec; 18(6):616-22. PubMed ID: 16962308
[TBL] [Abstract][Full Text] [Related]
37. Study on the treatment of the p15 gene combined with Bcr-abl-specific siRNA and STI571 for chronic myeloid leukemia.
Wang W; Du Y; Li NN; Lv FF; Lin GQ
Genet Mol Res; 2014 May; 13(2):4089-101. PubMed ID: 24938701
[TBL] [Abstract][Full Text] [Related]
38. Expression of oncogenic kinase Bcr-Abl impairs mitotic checkpoint and promotes aberrant divisions and resistance to microtubule-targeting agents.
Wolanin K; Magalska A; Kusio-Kobialka M; Podszywalow-Bartnicka P; Vejda S; McKenna SL; Mosieniak G; Sikora E; Piwocka K
Mol Cancer Ther; 2010 May; 9(5):1328-38. PubMed ID: 20442314
[TBL] [Abstract][Full Text] [Related]
39. Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation.
Rangatia J; Bonnet D
Leukemia; 2006 Jan; 20(1):68-76. PubMed ID: 16281073
[TBL] [Abstract][Full Text] [Related]
40. Resistance to apoptosis of HCW-2 cells can be overcome by curcumin- or vincristine-induced mitotic catastrophe.
Magalska A; Sliwinska M; Szczepanowska J; Salvioli S; Franceschi C; Sikora E
Int J Cancer; 2006 Oct; 119(8):1811-8. PubMed ID: 16721786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]